Panadol Pain Relief

Panadol is one of the world's most recognized over-the-counter pain relief brands, primarily containing paracetamol as its active ingredient. Originally introduced to the market in the mid-1950s, it quickly became a household name for treating headaches, fever, and minor aches. The brand's history is deeply rooted in the United Kingdom, where it was first developed by Frederick Stearns & Co. before evolving through various corporate mergers and acquisitions.

Today, Panadol is produced in several strategic manufacturing hubs around the world to meet global demand. Major production facilities are located in the United Kingdom, Ireland, and Australia, as well as various regional sites across Asia and Africa. This widespread manufacturing network ensures that the product is available in numerous formulations, including rapid-release caplets, soluble tablets, and pediatric suspensions.

Following a significant corporate demerger in 2022, Panadol is now under the ownership of Haleon, a dedicated consumer healthcare company. Haleon was formed as a spin-off from GSK (GlaxoSmithKline) and integrates the consumer health sectors of both GSK and Pfizer. Headquartered in Weybridge, United Kingdom, Haleon manages Panadol's global presence, continuing the brand's legacy as a leader in pain management across more than 80 countries.